z-logo
open-access-imgOpen Access
Can Patents Deter Innovation? The Anticommons in Biomedical Research
Author(s) -
Michael Heller,
Rebecca S. Eisenberg
Publication year - 1998
Publication title -
science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 12.556
H-Index - 1186
eISSN - 1095-9203
pISSN - 0036-8075
DOI - 10.1126/science.280.5364.698
Subject(s) - tragedy of the commons , intellectual property , business , commons , law and economics , upstream (networking) , metaphor , downstream (manufacturing) , product (mathematics) , tragedy (event) , political science , economics , marketing , sociology , law , engineering , social science , telecommunications , linguistics , philosophy , geometry , mathematics
The "tragedy of the commons" metaphor helps explain why people overuse shared resources. However, the recent proliferation of intellectual property rights in biomedical research suggests a different tragedy, an "anticommons" in which people underuse scarce resources because too many owners can block each other. Privatization of biomedical research must be more carefully deployed to sustain both upstream research and downstream product development. Otherwise, more intellectual property rights may lead paradoxically to fewer useful products for improving human health.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom